The Cooper Companies, Inc. logo
The Cooper Companies, Inc. (COO)
Compare

The Cooper Companies, Inc. (COO) PS Ratio: 3.13

Is The Cooper Companies, Inc.’s P/S ratio high or low?

The Cooper Companies, Inc.'s P/S ratio of 3.13 is 39% below its 5-year average of 5.10, near the low end of its 5-year range (2.79–8.43).

As of Sunday, June 14, 2026. 11.71% below its 12-month average of 3.55.

COO PS Ratio Chart

COO PS Ratio
3.13-12.32% 1Y
Zoom

COO Average PS Ratio Chart

COO Current vs Average PS Ratio Chart

COO PS Ratio Metrics

PS RATIO

3.13

PS RATIO AVG TTM

3.55

PS RATIO AVG 3Y

4.51

PS RATIO AVG 5Y

5.10

PS RATIO AVG 10Y

5.41

PS RATIO AVG 15Y

4.87

PS RATIO AVG 20Y

4.14

CURRENT VS TTM AVG

-11.71%

CURRENT VS 3Y AVG

-30.55%

CURRENT VS 5Y AVG

-38.58%

CURRENT VS 10Y AVG

-42.13%

CURRENT VS 15Y AVG

-35.79%

CURRENT VS 20Y AVG

-24.35%

COO Competitors' PS Ratio

NAMEMARKET CAPPS RATIOTTM3Y5Y
The Cooper Companies, Inc. (COO)$13.24B3.133.554.515.10
Solventum Corporation (SOLV)$13.66B1.681.561.481.48
Align Technology, Inc. (ALGN)$12.52B3.062.944.296.13
Baxter International Inc. (BAX)$10.77B0.951.001.301.80
Walgreens Boots Alliance, Inc. (WBA)$10.37B0.070.060.130.20
Hologic, Inc. (HOLX)$16.97B4.163.834.273.99
Charles River Laboratories International, Inc. (CRL)$9.03B2.282.132.363.07
Tempus AI, Inc. (TEM)$8.35B6.2710.8811.7611.76
Bio-Rad Laboratories, Inc. (BIO)$7.73B2.983.033.314.32
Moderna, Inc. (MRNA)$19.80B8.866.145.217.07

P/S vs. its own history

At 3.13, P/S is cheaper than usual, sitting higher than 31% of its 20-year history.

20-year low

0.49

median

4.23

20-year high

8.43

cheaperricher

Sales Valuation

P/S Ratio

3.13

Market Cap / Annual Revenue

The Cooper Companies, Inc. PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

The Cooper Companies, Inc. PS Ratio FAQ

What is the P/S ratio for The Cooper Companies, Inc. (COO)?
The P/S ratio for COO stock is 3.13.
Is The Cooper Companies, Inc.'s P/S ratio high or low?
The Cooper Companies, Inc.'s P/S ratio of 3.13 is 39% below its 5-year average of 5.10, near the low end of its 5-year range (2.79–8.43).
What is the TTM average P/S ratio for The Cooper Companies, Inc. (COO)?
The TTM average P/S ratio for COO stock is 3.55.
What is the 3Y average P/S ratio for The Cooper Companies, Inc. (COO)?
The 3Y average P/S ratio for COO stock is 4.51.
What is the 5Y average P/S ratio for The Cooper Companies, Inc. (COO)?
The 5Y average P/S ratio for COO stock is 5.10.
What is the 10Y average P/S ratio for The Cooper Companies, Inc. (COO)?
The 10Y average P/S ratio for COO stock is 5.41.
What is the 15Y average P/S ratio for The Cooper Companies, Inc. (COO)?
The 15Y average P/S ratio for COO stock is 4.87.
What is the 20Y average P/S ratio for The Cooper Companies, Inc. (COO)?
The 20Y average P/S ratio for COO stock is 4.14.

The Cooper Companies, Inc. PS Ratio History

DATEPS RATIO
2026-06-123.13
2026-06-113.11
2026-06-103.12
2026-06-093.16
2026-06-083.08
2026-06-053.10
2026-06-042.94
2026-06-032.86
2026-06-022.82
2026-06-012.85
2026-05-292.90
2026-05-282.89
2026-05-272.88
2026-05-262.94
2026-05-222.96
2026-05-212.98
2026-05-202.93
2026-05-192.91
2026-05-182.89
2026-05-152.82
2026-05-142.86
2026-05-132.82
2026-05-122.84
2026-05-112.79
2026-05-082.84
2026-05-072.90
2026-05-062.90
2026-05-052.90
2026-05-042.91
2026-05-012.95
2026-04-302.98
2026-04-292.91
2026-04-282.99
2026-04-273.05
2026-04-243.05
2026-04-233.08
2026-04-223.17
2026-04-213.19
2026-04-203.29
2026-04-173.32
2026-04-163.29
2026-04-153.33
2026-04-143.39
2026-04-133.40
2026-04-103.37
2026-04-093.39
2026-04-083.40
2026-04-073.30
2026-04-063.33
2026-04-023.32
2026-04-013.38
2026-03-313.39
2026-03-303.28
2026-03-273.31
2026-03-263.39
2026-03-253.39
2026-03-243.34
2026-03-233.33
2026-03-203.31
2026-03-193.35
2026-03-183.37
2026-03-173.41
2026-03-163.37
2026-03-133.31
2026-03-123.39
2026-03-113.49
2026-03-103.53
2026-03-093.59
2026-03-063.63
2026-03-053.88
2026-03-043.97
2026-03-034.04
2026-03-024.06
2026-02-274.05
2026-02-264.07
2026-02-254.04
2026-02-244.04
2026-02-234.01
2026-02-204.07
2026-02-194.05
2026-02-184.04
2026-02-173.97
2026-02-134.02
2026-02-123.95
2026-02-114.02
2026-02-103.95
2026-02-093.94
2026-02-063.97
2026-02-053.88
2026-02-043.92
2026-02-033.84
2026-02-023.90
2026-01-303.94
2026-01-293.89
2026-01-283.90
2026-01-273.91
2026-01-263.92
2026-01-233.93
2026-01-224.01
2026-01-214.00
2026-01-203.90
2026-01-163.99
2026-01-153.98
2026-01-143.95
2026-01-133.95
2026-01-124.03
2026-01-094.04
2026-01-084.02
2026-01-074.06
2026-01-064.08
2026-01-054.01
2026-01-023.93
2025-12-313.97
2025-12-303.99
2025-12-293.98
2025-12-264.00
2025-12-244.00
2025-12-234.01
2025-12-224.06
2025-12-194.01
2025-12-183.99
2025-12-173.99
2025-12-163.92
2025-12-153.95
2025-12-123.97
2025-12-113.97
2025-12-103.91
2025-12-093.80
2025-12-083.78
2025-12-053.94
2025-12-043.82
2025-12-033.77
2025-12-023.76
2025-12-013.84
2025-11-283.86
2025-11-263.86
2025-11-253.88
2025-11-243.77
2025-11-213.74
2025-11-203.53
2025-11-193.58
2025-11-183.58
2025-11-173.54
2025-11-143.58
2025-11-133.56
2025-11-123.59
2025-11-113.56
2025-11-103.51
2025-11-073.48
2025-11-063.42
2025-11-053.42
2025-11-043.43
2025-11-033.46
2025-10-313.47
2025-10-303.48
2025-10-293.45
2025-10-283.56
2025-10-273.61
2025-10-243.64
2025-10-233.69
2025-10-223.69
2025-10-213.72
2025-10-203.72
2025-10-173.57
2025-10-163.55
2025-10-153.41
2025-10-143.53
2025-10-133.44
2025-10-103.39
2025-10-093.46
2025-10-083.48
2025-10-073.42
2025-10-063.48
2025-10-033.49
2025-10-023.43
2025-10-013.38
2025-09-303.40
2025-09-293.36
2025-09-263.35
2025-09-253.32
2025-09-243.39
2025-09-233.35
2025-09-223.37
2025-09-193.38
2025-09-183.33
2025-09-173.19
2025-09-163.23
2025-09-153.25
2025-09-123.31
2025-09-113.39
2025-09-103.35
2025-09-093.38
2025-09-083.41
2025-09-053.38
2025-09-043.37
2025-09-033.33
2025-09-023.24
2025-08-293.34
2025-08-283.20
2025-08-273.73
2025-08-263.71
2025-08-253.70
2025-08-223.79
2025-08-213.68
2025-08-203.70
2025-08-193.72
2025-08-183.70
2025-08-153.69
2025-08-143.70
2025-08-133.74
2025-08-123.66
2025-08-113.57
2025-08-083.54
2025-08-073.48
2025-08-063.43
2025-08-053.50
2025-08-043.60
2025-08-013.57
2025-07-313.56
2025-07-303.64
2025-07-293.71
2025-07-283.67
2025-07-253.75
2025-07-243.71
2025-07-233.69
2025-07-223.68
2025-07-213.59
2025-07-183.65
2025-07-173.69
2025-07-163.66
2025-07-153.63
2025-07-143.70
2025-07-113.76
2025-07-103.86
2025-07-093.77
2025-07-083.74
2025-07-073.69
2025-07-033.69
2025-07-023.67
2025-07-013.66
2025-06-303.58
2025-06-273.58
2025-06-263.51
2025-06-253.50
2025-06-243.57
2025-06-233.50
2025-06-203.50
2025-06-183.51
2025-06-173.46
2025-06-163.51
2025-06-133.51
2025-06-123.57
2025-06-113.59
2025-06-103.66
2025-06-093.62
2025-06-063.64
2025-06-053.58
2025-06-043.39
2025-06-033.37
2025-06-023.37

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA
16,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White